PER 3.85% 13.5¢ percheron therapeutics limited

per-chart, page-1126

  1. 4,391 Posts.
    lightbulb Created with Sketch. 2050
    Up until Covid, I would have agreed. But I (personal opinion only) think the market looks at risk a bit differently now.

    Unless statistically significant results are announced, I think we will drift sideways. Maybe pumps prior to announcements, but no huge spurt until closer to Dec, maybe?

    If the right announcements hit, it will run, as the market cap is far lower than we would have been prior to covid.

    This market still doesn't tolerate risk as it once did. Opportunities for sone, nightmares for others.

    Many multiples of SP potential if we can replicate the previous trial.
 
watchlist Created with Sketch. Add PER (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.